Article L.233-8-II of Commercial Law (Code de commerce) and
Article 223-16 of the General Regulation of the French Financial Markets Authority
(AMF - Autorité des Marchés Financiers)
|Total number of outstanding shares forming the capital
|Number of shares with double voting rights||870,986|
|Total number of gross voting rights||10,065,919|
Number of shares without voting rights
|Total number of exercisable voting rights*||
*Real number of voting rights = total number of voting rights - number of shares without voting rights
If you would like to receive financial information about Naturex by e-mail, go to: www.naturex.com
|- 2014 third-quarter sales
- 2014 third-quarter results
- Annual revenue
- Annual results
|4 November 2014
28 November 2014
3 February 2015
31 March 2015
|- ACTIONARIA Show (Paris)||21-22 November 2014|
Naturex has been listed since October 1996 on Euronext in Paris, Segment B
|Total number of shares comprising the share capital: 9,194,933 (September 2014)
NATUREX is a component of the CAC®PME, CAC Small and Gaïa indexes.
Naturex is eligible for the "long only" Deferred Settlement Service (SRD) and French equity plans (PEA and PEA-PME).
Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY.
TICKER: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY
Naturex is the global leader in speciality plant-based natural ingredients. The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.
Naturex's head office is based in Avignon. The company employs 1,600 people with 8 sourcing offices located throughout the world and high-performance manufacturing operations across 16 sites in Europe, Morocco, the United States, Brazil, Australia and India. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries.
Tel.: +33 (0)4 90 23 78 28
Chief Financial Officer
Tel.: +33 (0)4 90 23 96 89
|Anne Catherine Bonjour
Actus Finance Press Relations
Tel.: +33 (0)1 53 67 36 93
Information relative au nombre total de droits de vote et d'actions composant le capital :
Communiqué intégral et original au format PDF :
Si le fichier PDF ne s'affiche pas ou pour le télécharger, cliquez ici.
Pour consulter le fichier PDF en intégralité, cliquez ici.
|NATUREX||Euronext Paris||79.95||0.34%||7 449|